Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection

Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik
doi: https://doi.org/10.1101/2021.06.24.21259218
Julia Schiffner
1University of Luebeck, Center for Infection and Inflammation Research, Luebeck, Germany; German Center for Infection Research (DZIF), Standort Hamburg-Borstel-Luebeck-Riems
2Health Protection Authority, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Insa Backhaus
3Institute of Medical Sociology, Centre for Health and Society, Medical Faculty and University Hospital, Heinrich-Heine-University, Düsseldorf, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Rimmele
2Health Protection Authority, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sören Schulz
2Health Protection Authority, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Till Möhlenkamp
2Health Protection Authority, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Maria Klemens
4Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorinja Zapf
4Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Solbach
1University of Luebeck, Center for Infection and Inflammation Research, Luebeck, Germany; German Center for Infection Research (DZIF), Standort Hamburg-Borstel-Luebeck-Riems
2Health Protection Authority, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Mischnik
2Health Protection Authority, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alexander.mischnik@luebeck.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Characterisation of the naturally acquired B and T cell immune responses to SARS-CoV-2 is important for the development of public health and vaccination strategies to manage the burden of COVID-19 disease. We conducted a prospective, longitudinal analysis in COVID-19 recovered patients at various time points over a 10-month period in order to determine how circulating antibody levels and interferon-gamma (IFN-γ) release by peripheral blood cells change over time following natural infection.

From March 2020 till January 2021, we enrolled 412 adults mostly with mild or moderate disease course. At each study visit, subjects donated peripheral blood for testing of anti-SARS-CoV-2 IgG antibodies and IFN-γ release after SARS-CoV-2 S-protein stimulation. Anti-SARS-CoV-2 IgG antibodies were identified in 316/412 (76.7%) of the patients and 215/412 (52.2%) had positive neutralizing antibody levels. Likewise, in 274/412 (66.5 %) positive IFN-γ release and IgG antibodies were detected. With respect to time after infection, both IgG antibody levels and IFN-γ concentrations decreased by about half within three hundred days. Statistically, IgG and IFN-γ production were closely associated, but on an individual basis we observed patients with high antibody titres but low IFN-γ levels and vice versa.

Our data suggest that immunological reaction is acquired in most individuals after infection with SARS-CoV-2 and is sustained in the majority of patients for at least 10 months after infection. Since no robust marker for protection against COVID-19 exists so far, we recommend utilizing both, IgG and IFN-γ release for an individual assessment of immunity status.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by the City of Luebeck and EUROIMMUN AG

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethical committee of the University of Luebeck approved the study (ref. 20-339).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing interests All authors declare no conflict of interest (including financial, commercial, political or personal).

  • Funding statement The study was funded by the City of Luebeck and EUROIMMUN AG

  • Ethical statement The ethical committee of the University of Luebeck approved the study (ref. 20-339)

Data Availability

All data are available if you contact the authors.

  • Abbreviations

    COVID-19
    coronavirus disease 19
    I
    confidence interval
    ELISA
    Enzyme-linked Immunosorbent Assay
    IgG
    immunoglobulin G
    IGRA
    Interferon-Gamma-Release Assay
    rt-PCR
    real-time polymerase chain reaction
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted June 25, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
    Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik
    medRxiv 2021.06.24.21259218; doi: https://doi.org/10.1101/2021.06.24.21259218
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
    Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik
    medRxiv 2021.06.24.21259218; doi: https://doi.org/10.1101/2021.06.24.21259218

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (160)
    • Allergy and Immunology (413)
    • Anesthesia (90)
    • Cardiovascular Medicine (855)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (248)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
    • Epidemiology (8550)
    • Forensic Medicine (4)
    • Gastroenterology (383)
    • Genetic and Genomic Medicine (1744)
    • Geriatric Medicine (167)
    • Health Economics (371)
    • Health Informatics (1237)
    • Health Policy (619)
    • Health Systems and Quality Improvement (467)
    • Hematology (196)
    • HIV/AIDS (372)
    • Infectious Diseases (except HIV/AIDS) (10281)
    • Intensive Care and Critical Care Medicine (552)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (210)
    • Neurology (1670)
    • Nursing (97)
    • Nutrition (248)
    • Obstetrics and Gynecology (325)
    • Occupational and Environmental Health (450)
    • Oncology (926)
    • Ophthalmology (263)
    • Orthopedics (100)
    • Otolaryngology (172)
    • Pain Medicine (112)
    • Palliative Medicine (40)
    • Pathology (252)
    • Pediatrics (534)
    • Pharmacology and Therapeutics (247)
    • Primary Care Research (207)
    • Psychiatry and Clinical Psychology (1764)
    • Public and Global Health (3832)
    • Radiology and Imaging (622)
    • Rehabilitation Medicine and Physical Therapy (319)
    • Respiratory Medicine (520)
    • Rheumatology (207)
    • Sexual and Reproductive Health (165)
    • Sports Medicine (157)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (74)